Left ventricular opacification at rest and during stress

American Journal of Cardiology

Volumn 90, Issue 10 SUPPL. 1, 2002, Pages 21-27

  Grayburn, Paul A ^a,b   Mulvagh, Sharon ^a   Crouse, Linda ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; FS 069; PERFLUOROPENTANE; SONOVUE;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; COST; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG SAFETY; EDUCATION; EMERGENCY WARD; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; IMAGE QUALITY; INJECTION; INTENSIVE CARE UNIT; PRIORITY JOURNAL; REIMBURSEMENT; REST; STRESS; THROMBUS;

EID: 0037131935     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02862-X     Document Type: Article

References (40)

1. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
2. Visser C.A., Kan G., David G.K., Lie K.I., Durrer D. Echocardiographic-cineangiographic correlation in detecting left ventricular aneurysm a prospective study of 422 patients . Am J Cardiol. 50:1982;337-341.
3. Freeman A.P., Giles R.W., Walsh W.F., Fisher R., Murray I.P., Wilcken D.E. Regional left ventricular wall motion assessment comparison of two-dimensional echocardiography and radionuclide angiography with contrast angiography in healed myocardial infarction . Am J Cardiol. 56:1985;8-12.
4. Spencer K.T., Bednarz J., Rafter P.G., Korcarz C., Lang R.M. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol. 82:1998;794-799.
5. Kasprzak J.D., Paelinck B., Ten Cate F.J., Vletter W.B., de Jong N., Poldermans D., Elhendy A., Bouakaz A., Roelandt J.R. Comparison of native and contrast-enhanced harmonic echocardiography for visualization of left ventricular endocardial border. Am J Cardiol. 83:1999;211-217.
6. Caidahl K., Kazzam E., Lidberg J., Neumann A.G., Nordanstig J., Rantapaa D.S., Waldenstrom A., Wikh R. New concept in echocardiography harmonic imaging of tissue without use of contrast agent . Lancet. 352:1998;1264-1270.
7. Lindner J.R., Dent J.M., Moos S.P., Jayaweera A.R., Kaul S. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex. Am J Cardiol. 79:1997;1657-1662.
8. Crouse L.J., Cheirif J., Hanly D.E., Kisslo J.A., Labovitz A.J., Raichlen J.S., Schutz R.W., Shah P.M., Smith M.D. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography results of the Phase III Albunex Multicenter Trial . J Am Coll Cardiol. 22:1993;1494-1500.
9. Feinstein S.B., Cheirif J., Ten Cate F.J., Silverman P.R., Heidenreich P.A., Dick C., Desir R.M., Armstrong W.F., Quinones M.A., Shah P.M. Safety and efficacy of a new transpulmonary ultrasound contrast agent initial multicenter clinical results . J Am Coll Cardiol. 16:1990;316-324.
10. Gandhok N.K., Block R., Ostoic T., Rawal M., Hickle P., Devries S., Feinstein S.B. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. J Am Soc Echocardiogr. 10:1997;25-30.
11. Grayburn P.A., Weiss J.L., Hack T.C., Klodas E., Raichlen J.S., Vannan M.A., Klein A.L., Kitzman D.W., Chrysant S.G., Cohen J.L., et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol. 32:1998;230-236.
12. Cohen J.L., Cheirif J., Segar D.S., Gillam L.D., Gottdiener J.S., Hausnerova E., Bruns D.E. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III multicenter trial. J Am Coll Cardiol. 32:1998;746-752.
13. Nanda N.C., Wistran D.C., Karlsberg R.P., Hack T.C., Smith W.B., Foley D.A., Picard M.H., Cotter B. Multicenter evaluation of SonoVue for improved endocardial border delineation. Echocardiography. 19:2002;27-36.
14. Senior R., Andersson O., Caidahl K., Carlens P., Herregods M.C., Jenni R., Kenny A., Melcher A., Svedenhag J., Vanoverschelde J.L., et al. Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent a European multicenter study . Echocardiography. 17:2000;705-711.
15. de Jong N., Ten Cate F.J., Lancee C.T., Roelandt J.R., Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics. 29:1991;324-330.
16. Hundley W.G., Kizilbash A.M., Afridi I., Franco F., Peshock R.M., Grayburn P.A. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction comparison with cine magnetic resonance imaging . J Am Coll Cardiol. 32:1998;1426-1432.
17. Zotz R.J., Genth S., Waaler A., Erbel R., Meyer J. Left ventricular volume determination using Albunex. J Am Soc Echocardiogr. 9:1996;1-8.
18. Hundley W.G., Kizilbash A.M., Afridi I., Franco F., Peshock R.M., Grayburn P.A. Effect of contrast enhancement on transthoracic echocardiographic assessment of left ventricular regional wall motion. Am J Cardiol. 84:1999;1365-1369.
19. Marwick T.H., Nemec J.J., Pashkow F.J., Stewart W.J., Salcedo E.E. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol. 19:1992;74-81.
20. Falcone R.A., Marcovitz P.A., Perez J.E., Dittrich H.C., Hopkins W.E., Armstrong W.F. Intravenous Albunex during dobutamine stress echocardiography enhanced localization of left ventricular endocardial borders . Am Heart J. 130:1995;254-258.
21. Schroder K., Agrawal R., Voller H., Schlief R., Schroder R. Improvement of endocardial border delineation in suboptimal stress-echocardiograms using the new left heart contrast agent SH U 508 A. Int J Card Imaging. 10:1994;45-51.
22. Porter T.R., Xie F., Kricsfeld A., Chiou A., Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol. 23:1994;1440-1443.
23. Malhotra V., Nwogu J., Bondmass M.D., Bean M., Bieniarz T., Tertell M., Conliss M., Devries S. Is the technically limited echocardiographic study an endangered species? Endocardial border definition with native tissue harmonic imaging and Optison contrast a review of 200 cases . J Am Soc Echocardiogr. 13:2000;771-773.
24. Rainbird A.J., Mulvagh S.L., Oh J.K., McCully R.B., Klarich K.W., Shub C., Mahoney D.W., Pellikka P.A. Contrast dobutamine stress echocardiography clinical practice assessment in 300 consecutive patients . J Am Soc Echocardiogr. 14:2001;378-385.
25. Shaw L.J. Impact of contrast echocardiography on diagnostic algorithms pharmacoeconomic implications . Clin Cardiol. 20:1997;I39-I48.
26. Shaw L.J., Monaghan M.J., Nihoyannopolous P. Clinical and economic outcomes assessment with myocardial contrast echocardiography. Heart. 82:(suppl 3):1999;III16-III21.
27. Stratton J.R., Lighty G.W. Jr, Pearlman A.S., Ritchie J.L. Detection of left ventricular thrombus by two-dimensional echocardiography sensitivity, specificity, and causes of uncertainty . Circulation. 66:1982;156-166.
28. Ezekowitz M.D., Wilson D.A., Smith E.O., Burow R.D., Harrison L.H. Jr, Parker D.E., Elkins R.C., Peyton M., Taylor F.B. Comparison of indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med. 306:1982;1509-1513.
29. Visser C.A., Kan G., Meltzer R.S., Dunning A.J., Roelandt J. Embolic potential of left ventricular thrombus after myocardial infarction a two-dimensional echocardiographic study of 119 patients . J Am Coll Cardiol. 5:1985;1276-1280.
30. Asanuma T., Tanabe K., Yoshitomi H., Shimizu H., Okada S., Shimada T. Differential diagnosis of left ventricular mural thrombi by myocardial contrast echocardiography a preliminary study . Jpn Circ J. 63:1999;50-52.
31. Ota T., Fleishman C.E., Strub M., Stetten G., Ohazama C.J., von Ramm O.T., Kisslo J. Real-time, three-dimensional echocardiography feasibility of dynamic right ventricular volume measurement with saline contrast . Am Heart J. 137:1999;958-966.
32. Reilly J.P., Tunick P.A., Timmermans R.J., Stein B., Rosenzweig B.P., Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol. 35:2000;485-490.
33. Main M.L., Grayburn P.A. Clinical applications of transpulmonary contrast echocardiography. Am Heart J. 137:1999;144-153.
34. Sheikh K., Smith S.W., von Ramm O., Kisslo J. Real-time, three-dimensional echocardiography feasibility and initial use . Echocardiography. 8:1991;119-125.
35. Collins M., Hsieh A., Ohazama C.J., Ota T., Stetten G., Donovan C.L., Kisslo J., Ryan T. Assessment of regional wall motion abnormalities with real-time 3-dimensional echocardiography. J Am Soc Echocardiogr. 12:1999;7-14.
36. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 97:1998;473-483.
37. Vandenberg B.F., Melton H.E. Acoustic lability of albumin microspheres. J Am Soc Echocardiogr. 7:1994;582-589.
38. Vuille C., Nidorf M., Morrissey R.L., Newell J.B., Weyman A.E., Picard M.H. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents. J Am Soc Echocardiogr. 7:1994;347-354.
39. Shapiro J.R., Reisner S.A., Lichtenberg G.S., Meltzer R.S. Intravenous contrast echocardiography with use of sonicated albumin in humans systolic disappearance of left ventricular contrast after transpulmonary transmission . J Am Coll Cardiol. 16:1990;1603-1607.
40. Mulvagh S.L., DeMaria A.N., Feinstein S.B., Burns P.N., Kaul S., Miller J.G., Monaghan M., Porter T.R., Shaw L.J., Villanueva F.S. Contrast echocardiography current and future applications . J Am Soc Echocardiogr. 13:2000;331-342.